In this illustrated photo, a packet of mifepristone is seen at Wellspring Center, Wyoming’s last abortion clinic, in Casper, Wyoming, on March 10, 2025.
Natalie Bering | Getty Images
The U.S. Supreme Court on Monday temporarily lifted a lower court’s injunction against mailing the abortion drug mifepristone.
The administrative suspension of mifepristone’s mailing ban issued by the 5th Circuit Court of Appeals on Friday will last until at least May 11 at 5:00 pm ET, but may be extended thereafter.
Granting the stay, Supreme Court Justice Samuel Alito gave Louisiana until 5 p.m. Thursday to respond to a request to block the Fifth Circuit’s ruling while litigation over the issue progresses.
Two drug companies, Danko Laboratories and GenBioPro, asked the Supreme Court over the weekend to lift the ban on mifepristone distributed by mail.
The drug is used in about two-thirds of all abortions in the United States.
Louisiana was suing the Food and Drug Administration over its 2023 decision to eliminate a rule requiring mifepristone to be administered directly.
